stanford school of medicine logotitle logo
advanced

 

 

Cardiology

 

Endocrinology

 

Gastroenterology

 

General Inpatient Medicine

 

Hematology

 

Infectious Disease

 

Nephrology

 

Neurology

 

Oncology

 

Outpatient & Preventative Medicine

 

Palliative Care

 

Psychiatry

 

Pulmonary/Critical Care

 

Rheumatology

Post Transplant Lymphoproliferative Disease (PTLD) - Pearls

 

  • PTLD is almost always a B-cell neoplasm, and is associate with EBV in >80% of cases
  • pediatric patients are at higher risk, primarily b/c most of them are EBV-negative at time of transplant
  • incidence after solid organ tx is highest in lung tx>>heart>>kidney 
  • risk is most related to the degree of immunosuppression and the pt's pre-transplant EBV status
  • PTLD consists of a wide variety of lymphoproliferative diseases.  The WHO classifies them into 3 categories: early lesions (plasmocytic hyperplasia, or mononucleosis-like lesions), monomorphic PTLD: B-cell neoplasms (diffuse large B-cell lymphoma, Burkitt lymphoma, plasma cell myeloma etc.) and polymorphic PTLD (having multiple cell types, often related to primary EBV infxn)
  • Epidemiology:
    • incidence after solid organ tx is highest in lung tx>>heart>>kidney 
    • risk is most related to the degree of immunosuppression and the pt's pre-transplant EBV status
    • with respect to immunosuppressive drugs, tacrolimus is associated with higher rates of PTLD than cyclosporine or cellcept
    • pediatric patients are at higher risk, primarily b/c most of them are EBV-negative at time of transplant
  • Clinical presentation is often insidious, like an infectious mononucleosis syndrome, also can cause cytopenias and a monoclonal B-cell proliferation.  Over 50% of patients present with an extranodal mass (can be in the GI tract, lungs, skin, CNS); up to 25% can present with infiltration into the graft organ
  • Diagnosis requires a high level of suspicion as the disorder often presents subtly and extranodal; radiographic evidence of a mass and elevated serum markers (such as LDH) are suggestive of PTLD in a transplant pt—PET CT can be helpful in making the diagnosis
  • PTLD consists of a wide variety of lymphoproliferative diseases.  The WHO classifies them into 3 categories: early lesions (plasmocytic hyperplasia, or mononucleosis-like lesions), monomorphic PTLD: B-cell neoplasms (diffuse large B-cell lymphoma, Burkitt lymphoma, plasma cell myeloma etc.) and polymorphic PTLD (having multiple cell types, often related to primary EBV infxn)

 

(Victoria Kelly MD, 11/2/10, 6/9/11)